A network meta-analysis of therapies for hyperphosphatemia in CKD based on randomized trials
Abstract To update the efficacy and safety of different drugs for the treatment of patients with hyperphosphatemia in chronic kidney disease, we conducted a network meta-analysis of 22 therapies for the treatment of uncontrolled hyperphosphatemia in patients with chronic kidney disease (CKD). All ra...
Saved in:
Main Authors: | Congyang Zheng, Jia Liu, Tao Wang, Haiyang Hu, Yuanyuan Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2025-01-01
|
Series: | Scientific Reports |
Subjects: | |
Online Access: | https://doi.org/10.1038/s41598-024-84942-8 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Disparity of serum uric acid threshold for CKD among hypertensive and non-hypertensive individuals
by: Bowen Zhu, et al.
Published: (2024-12-01) -
Cystatin C as a predictor of acute renal damage after radical surgical treatment in patients with muscle-invasive bladder cancer
by: A. I. Tarasenko, et al.
Published: (2021-06-01) -
Phosphate binder in dialysis: a cross-sectional study of patients' adherence and pill burden
by: Brunelle Bruna Scavello Coelho Ferezin, et al.
Published: (2025-01-01) -
CKD: A Guide to Higher Fiber Foods
by: Wendy J. Dahl, et al.
Published: (2018-01-01) -
CKD: A Guide to Higher Fiber Foods
by: Wendy J. Dahl, et al.
Published: (2018-01-01)